Please assess the completion status of the following clinical trial:

Trial Title: Impact of Opioid Free Anesthesia on Outcome After DIEPflap Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria: DIEPflap unilat or bilat woman between 18 and 60 years old-~Exclusion Criteria: none~* allergy to any of the drugs used in anesthesia

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- opioid free anesthesia (OFA) (Type: None): The method of reaching OFA: Dexmedetomidine was given in a first loading dose 15 minutes before induction, a second loading dose at induction followed by an infusion for maintenance. Lidocaine is given as a loading dose at induction followed by infusion for maintenance. A Ketamine loading dose is given at induction with an extra bolus before incision followed by an infusion.
- opioid anesthesia (OA) (Type: None): OA was induced with sufentanil and continued with extra boli or a continuous infusion of remifentanil.

Based on this trial design, predict the completion outcome and termination type (if applicable).